Next Article in Journal
Use of Peroxyacetic Acid as Green Chemical on Yield and Sensorial Quality in Watercress (Nasturtium officinale R. Br.) Under Soilless Culture
Previous Article in Journal
Genetic and Epigenetic Traits as Biomarkers in Colorectal Cancer
Open AccessArticle

Dynamic Structure-Based Pharmacophore Model Development: A New and Effective Addition in the Histone Deacetylase 8 (HDAC8) Inhibitor Discovery

Division of Applied Life Science (BK21 Program), Systems and Synthetic Agrobiotech Center (SSAC), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Research Institute of Natural Science (RINS), Gyeongsang National University (GNU), 501 Jinju-daero, Gazwa-dong, Jinju 660-701, Korea
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2011, 12(12), 9440-9462; https://doi.org/10.3390/ijms12129440
Received: 29 August 2011 / Revised: 15 November 2011 / Accepted: 8 December 2011 / Published: 19 December 2011
(This article belongs to the Section Physical Chemistry, Theoretical and Computational Chemistry)
Histone deacetylase 8 (HDAC8) is an enzyme involved in deacetylating the amino groups of terminal lysine residues, thereby repressing the transcription of various genes including tumor suppressor gene. The over expression of HDAC8 was observed in many cancers and thus inhibition of this enzyme has emerged as an efficient cancer therapeutic strategy. In an effort to facilitate the future discovery of HDAC8 inhibitors, we developed two pharmacophore models containing six and five pharmacophoric features, respectively, using the representative structures from two molecular dynamic (MD) simulations performed in Gromacs 4.0.5 package. Various analyses of trajectories obtained from MD simulations have displayed the changes upon inhibitor binding. Thus utilization of the dynamically-responded protein structures in pharmacophore development has the added advantage of considering the conformational flexibility of protein. The MD trajectories were clustered based on single-linkage method and representative structures were taken to be used in the pharmacophore model development. Active site complimenting structure-based pharmacophore models were developed using Discovery Studio 2.5 program and validated using a dataset of known HDAC8 inhibitors. Virtual screening of chemical database coupled with drug-like filter has identified drug-like hit compounds that match the pharmacophore models. Molecular docking of these hits reduced the false positives and identified two potential compounds to be used in future HDAC8 inhibitor design. View Full-Text
Keywords: molecular dynamics simulation; pharmacophore; virtual screening; Lipinski’s rule; molecular docking molecular dynamics simulation; pharmacophore; virtual screening; Lipinski’s rule; molecular docking
Show Figures

Graphical abstract

MDPI and ACS Style

Thangapandian, S.; John, S.; Lee, Y.; Kim, S.; Lee, K.W. Dynamic Structure-Based Pharmacophore Model Development: A New and Effective Addition in the Histone Deacetylase 8 (HDAC8) Inhibitor Discovery. Int. J. Mol. Sci. 2011, 12, 9440-9462. https://doi.org/10.3390/ijms12129440

AMA Style

Thangapandian S, John S, Lee Y, Kim S, Lee KW. Dynamic Structure-Based Pharmacophore Model Development: A New and Effective Addition in the Histone Deacetylase 8 (HDAC8) Inhibitor Discovery. International Journal of Molecular Sciences. 2011; 12(12):9440-9462. https://doi.org/10.3390/ijms12129440

Chicago/Turabian Style

Thangapandian, Sundarapandian; John, Shalini; Lee, Yuno; Kim, Songmi; Lee, Keun Woo. 2011. "Dynamic Structure-Based Pharmacophore Model Development: A New and Effective Addition in the Histone Deacetylase 8 (HDAC8) Inhibitor Discovery" Int. J. Mol. Sci. 12, no. 12: 9440-9462. https://doi.org/10.3390/ijms12129440

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop